Global Lumpectomy

Lumpectomy Comprehensive Study by Type (Surgical Tools, Lumpectomy Systems), End User (Hospitals, Clinics, Ambulatory Surgical Centers) Players and Region - Global Market Outlook to 2030

Lumpectomy Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Growing incidences of breast cancer will help to boost global lumpectomy market. Lumpectomy is also called as breast-conserving surgery and wide local excision. Lumpectomy is a type of surgery to remove cancer or other abnormal tissue from the breast. In this process the only portion of the breast. It helps in confirming the diagnosis and complete absence of cancer. Additionally, it is a premier treatment option for some women with early-stage breast cancer.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia- Pacific
UnitValue (USD Million)
Key Companies ProfiledSanarus (United States), ClearCut Medical (Israel), BD (United States), Vector Surgical (United States), Dune Medical Devices (Georgia), Medtronic PLC (Ireland), ZEISS (Germany), Hologic, Inc. (United States), Novian Health, Inc. (United States) and Cianna Medical (Merit Medical Systems, Inc.) (United States)


This growth is primarily driven by Increase in Prevalence of Breast Cancer and Growing In Government Initiative.

Globally, a noticeable market trend is evident Fueling Usage of Mammography for Breast Cancer Detection The Diseases & Therapeutic Areas sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Sanarus (United States), ClearCut Medical (Israel), BD (United States), Vector Surgical (United States), Dune Medical Devices (Georgia), Medtronic PLC (Ireland), ZEISS (Germany), Hologic, Inc. (United States), Novian Health, Inc. (United States) and Cianna Medical (Merit Medical Systems, Inc.) (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth.

Key Developments in the Market:
On 25th April 2019, Hologic, Inc. has announced global commercial availability of the Trident® HD specimen radiography system, a next-generation solution that delivers enhanced image quality, improved workflow, and instant sample verification during breast-conserving surgeries as well as stereotactic breast biopsies.
On 12th February 2019, Dune Medical Devices recently reached the halfway point in a Post-Approval Study (PAS) for MarginProbe, with over 275 patients enrolled in the third Randomized Controlled trial on MarginProbe.

Influencing Trend:
Fueling Usage of Mammography for Breast Cancer Detection and Upsurge Awareness of Breast Cancer

Market Growth Drivers:
Increase in Prevalence of Breast Cancer and Growing In Government Initiative

Challenges:
Unavailability of Government Programs for Young Women

Restraints:
Stringent Government Regulations about Testing and High Cost of Procedure

Opportunities:
Technological Advancement in Lumpectomy Market and Huge Opportunity in Emerging Economic and Highest Growth Region

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Lumpectomy Market
- Analysis about New Entrants in Lumpectomy Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Lumpectomy Study Sheds Light on
— The Lumpectomy Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Lumpectomy industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Lumpectomy industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Surgical Tools
  • Lumpectomy Systems
By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Prevalence of Breast Cancer
      • 3.2.2. Growing In Government Initiative
    • 3.3. Market Challenges
      • 3.3.1. Unavailability of Government Programs for Young Women
    • 3.4. Market Trends
      • 3.4.1. Fueling Usage of Mammography for Breast Cancer Detection
      • 3.4.2. Upsurge Awareness of Breast Cancer
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Lumpectomy, by Type, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Lumpectomy (Value)
      • 5.2.1. Global Lumpectomy by: Type (Value)
        • 5.2.1.1. Surgical Tools
        • 5.2.1.2. Lumpectomy Systems
      • 5.2.2. Global Lumpectomy by: End User (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Ambulatory Surgical Centers
      • 5.2.3. Global Lumpectomy Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Lumpectomy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sanarus (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. ClearCut Medical (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BD (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Vector Surgical (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Dune Medical Devices (Georgia)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Medtronic PLC (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ZEISS (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Hologic, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Novian Health, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Cianna Medical (Merit Medical Systems, Inc.) (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Lumpectomy Sale, by Type, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Lumpectomy (Value)
      • 7.2.1. Global Lumpectomy by: Type (Value)
        • 7.2.1.1. Surgical Tools
        • 7.2.1.2. Lumpectomy Systems
      • 7.2.2. Global Lumpectomy by: End User (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Ambulatory Surgical Centers
      • 7.2.3. Global Lumpectomy Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Lumpectomy: by Type(USD Million)
  • Table 2. Lumpectomy Surgical Tools , by Region USD Million (2018-2023)
  • Table 3. Lumpectomy Lumpectomy Systems , by Region USD Million (2018-2023)
  • Table 4. Lumpectomy: by End User(USD Million)
  • Table 5. Lumpectomy Hospitals , by Region USD Million (2018-2023)
  • Table 6. Lumpectomy Clinics , by Region USD Million (2018-2023)
  • Table 7. Lumpectomy Ambulatory Surgical Centers , by Region USD Million (2018-2023)
  • Table 8. South America Lumpectomy, by Country USD Million (2018-2023)
  • Table 9. South America Lumpectomy, by Type USD Million (2018-2023)
  • Table 10. South America Lumpectomy, by End User USD Million (2018-2023)
  • Table 11. Brazil Lumpectomy, by Type USD Million (2018-2023)
  • Table 12. Brazil Lumpectomy, by End User USD Million (2018-2023)
  • Table 13. Argentina Lumpectomy, by Type USD Million (2018-2023)
  • Table 14. Argentina Lumpectomy, by End User USD Million (2018-2023)
  • Table 15. Rest of South America Lumpectomy, by Type USD Million (2018-2023)
  • Table 16. Rest of South America Lumpectomy, by End User USD Million (2018-2023)
  • Table 17. Asia Pacific Lumpectomy, by Country USD Million (2018-2023)
  • Table 18. Asia Pacific Lumpectomy, by Type USD Million (2018-2023)
  • Table 19. Asia Pacific Lumpectomy, by End User USD Million (2018-2023)
  • Table 20. China Lumpectomy, by Type USD Million (2018-2023)
  • Table 21. China Lumpectomy, by End User USD Million (2018-2023)
  • Table 22. Japan Lumpectomy, by Type USD Million (2018-2023)
  • Table 23. Japan Lumpectomy, by End User USD Million (2018-2023)
  • Table 24. India Lumpectomy, by Type USD Million (2018-2023)
  • Table 25. India Lumpectomy, by End User USD Million (2018-2023)
  • Table 26. South Korea Lumpectomy, by Type USD Million (2018-2023)
  • Table 27. South Korea Lumpectomy, by End User USD Million (2018-2023)
  • Table 28. Taiwan Lumpectomy, by Type USD Million (2018-2023)
  • Table 29. Taiwan Lumpectomy, by End User USD Million (2018-2023)
  • Table 30. Australia Lumpectomy, by Type USD Million (2018-2023)
  • Table 31. Australia Lumpectomy, by End User USD Million (2018-2023)
  • Table 32. Rest of Asia-Pacific Lumpectomy, by Type USD Million (2018-2023)
  • Table 33. Rest of Asia-Pacific Lumpectomy, by End User USD Million (2018-2023)
  • Table 34. Europe Lumpectomy, by Country USD Million (2018-2023)
  • Table 35. Europe Lumpectomy, by Type USD Million (2018-2023)
  • Table 36. Europe Lumpectomy, by End User USD Million (2018-2023)
  • Table 37. Germany Lumpectomy, by Type USD Million (2018-2023)
  • Table 38. Germany Lumpectomy, by End User USD Million (2018-2023)
  • Table 39. France Lumpectomy, by Type USD Million (2018-2023)
  • Table 40. France Lumpectomy, by End User USD Million (2018-2023)
  • Table 41. Italy Lumpectomy, by Type USD Million (2018-2023)
  • Table 42. Italy Lumpectomy, by End User USD Million (2018-2023)
  • Table 43. United Kingdom Lumpectomy, by Type USD Million (2018-2023)
  • Table 44. United Kingdom Lumpectomy, by End User USD Million (2018-2023)
  • Table 45. Netherlands Lumpectomy, by Type USD Million (2018-2023)
  • Table 46. Netherlands Lumpectomy, by End User USD Million (2018-2023)
  • Table 47. Rest of Europe Lumpectomy, by Type USD Million (2018-2023)
  • Table 48. Rest of Europe Lumpectomy, by End User USD Million (2018-2023)
  • Table 49. MEA Lumpectomy, by Country USD Million (2018-2023)
  • Table 50. MEA Lumpectomy, by Type USD Million (2018-2023)
  • Table 51. MEA Lumpectomy, by End User USD Million (2018-2023)
  • Table 52. Middle East Lumpectomy, by Type USD Million (2018-2023)
  • Table 53. Middle East Lumpectomy, by End User USD Million (2018-2023)
  • Table 54. Africa Lumpectomy, by Type USD Million (2018-2023)
  • Table 55. Africa Lumpectomy, by End User USD Million (2018-2023)
  • Table 56. North America Lumpectomy, by Country USD Million (2018-2023)
  • Table 57. North America Lumpectomy, by Type USD Million (2018-2023)
  • Table 58. North America Lumpectomy, by End User USD Million (2018-2023)
  • Table 59. United States Lumpectomy, by Type USD Million (2018-2023)
  • Table 60. United States Lumpectomy, by End User USD Million (2018-2023)
  • Table 61. Canada Lumpectomy, by Type USD Million (2018-2023)
  • Table 62. Canada Lumpectomy, by End User USD Million (2018-2023)
  • Table 63. Mexico Lumpectomy, by Type USD Million (2018-2023)
  • Table 64. Mexico Lumpectomy, by End User USD Million (2018-2023)
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Lumpectomy: by Type(USD Million)
  • Table 76. Lumpectomy Surgical Tools , by Region USD Million (2025-2030)
  • Table 77. Lumpectomy Lumpectomy Systems , by Region USD Million (2025-2030)
  • Table 78. Lumpectomy: by End User(USD Million)
  • Table 79. Lumpectomy Hospitals , by Region USD Million (2025-2030)
  • Table 80. Lumpectomy Clinics , by Region USD Million (2025-2030)
  • Table 81. Lumpectomy Ambulatory Surgical Centers , by Region USD Million (2025-2030)
  • Table 82. South America Lumpectomy, by Country USD Million (2025-2030)
  • Table 83. South America Lumpectomy, by Type USD Million (2025-2030)
  • Table 84. South America Lumpectomy, by End User USD Million (2025-2030)
  • Table 85. Brazil Lumpectomy, by Type USD Million (2025-2030)
  • Table 86. Brazil Lumpectomy, by End User USD Million (2025-2030)
  • Table 87. Argentina Lumpectomy, by Type USD Million (2025-2030)
  • Table 88. Argentina Lumpectomy, by End User USD Million (2025-2030)
  • Table 89. Rest of South America Lumpectomy, by Type USD Million (2025-2030)
  • Table 90. Rest of South America Lumpectomy, by End User USD Million (2025-2030)
  • Table 91. Asia Pacific Lumpectomy, by Country USD Million (2025-2030)
  • Table 92. Asia Pacific Lumpectomy, by Type USD Million (2025-2030)
  • Table 93. Asia Pacific Lumpectomy, by End User USD Million (2025-2030)
  • Table 94. China Lumpectomy, by Type USD Million (2025-2030)
  • Table 95. China Lumpectomy, by End User USD Million (2025-2030)
  • Table 96. Japan Lumpectomy, by Type USD Million (2025-2030)
  • Table 97. Japan Lumpectomy, by End User USD Million (2025-2030)
  • Table 98. India Lumpectomy, by Type USD Million (2025-2030)
  • Table 99. India Lumpectomy, by End User USD Million (2025-2030)
  • Table 100. South Korea Lumpectomy, by Type USD Million (2025-2030)
  • Table 101. South Korea Lumpectomy, by End User USD Million (2025-2030)
  • Table 102. Taiwan Lumpectomy, by Type USD Million (2025-2030)
  • Table 103. Taiwan Lumpectomy, by End User USD Million (2025-2030)
  • Table 104. Australia Lumpectomy, by Type USD Million (2025-2030)
  • Table 105. Australia Lumpectomy, by End User USD Million (2025-2030)
  • Table 106. Rest of Asia-Pacific Lumpectomy, by Type USD Million (2025-2030)
  • Table 107. Rest of Asia-Pacific Lumpectomy, by End User USD Million (2025-2030)
  • Table 108. Europe Lumpectomy, by Country USD Million (2025-2030)
  • Table 109. Europe Lumpectomy, by Type USD Million (2025-2030)
  • Table 110. Europe Lumpectomy, by End User USD Million (2025-2030)
  • Table 111. Germany Lumpectomy, by Type USD Million (2025-2030)
  • Table 112. Germany Lumpectomy, by End User USD Million (2025-2030)
  • Table 113. France Lumpectomy, by Type USD Million (2025-2030)
  • Table 114. France Lumpectomy, by End User USD Million (2025-2030)
  • Table 115. Italy Lumpectomy, by Type USD Million (2025-2030)
  • Table 116. Italy Lumpectomy, by End User USD Million (2025-2030)
  • Table 117. United Kingdom Lumpectomy, by Type USD Million (2025-2030)
  • Table 118. United Kingdom Lumpectomy, by End User USD Million (2025-2030)
  • Table 119. Netherlands Lumpectomy, by Type USD Million (2025-2030)
  • Table 120. Netherlands Lumpectomy, by End User USD Million (2025-2030)
  • Table 121. Rest of Europe Lumpectomy, by Type USD Million (2025-2030)
  • Table 122. Rest of Europe Lumpectomy, by End User USD Million (2025-2030)
  • Table 123. MEA Lumpectomy, by Country USD Million (2025-2030)
  • Table 124. MEA Lumpectomy, by Type USD Million (2025-2030)
  • Table 125. MEA Lumpectomy, by End User USD Million (2025-2030)
  • Table 126. Middle East Lumpectomy, by Type USD Million (2025-2030)
  • Table 127. Middle East Lumpectomy, by End User USD Million (2025-2030)
  • Table 128. Africa Lumpectomy, by Type USD Million (2025-2030)
  • Table 129. Africa Lumpectomy, by End User USD Million (2025-2030)
  • Table 130. North America Lumpectomy, by Country USD Million (2025-2030)
  • Table 131. North America Lumpectomy, by Type USD Million (2025-2030)
  • Table 132. North America Lumpectomy, by End User USD Million (2025-2030)
  • Table 133. United States Lumpectomy, by Type USD Million (2025-2030)
  • Table 134. United States Lumpectomy, by End User USD Million (2025-2030)
  • Table 135. Canada Lumpectomy, by Type USD Million (2025-2030)
  • Table 136. Canada Lumpectomy, by End User USD Million (2025-2030)
  • Table 137. Mexico Lumpectomy, by Type USD Million (2025-2030)
  • Table 138. Mexico Lumpectomy, by End User USD Million (2025-2030)
  • Table 139. Research Programs/Design for This Report
  • Table 140. Key Data Information from Secondary Sources
  • Table 141. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Lumpectomy: by Type USD Million (2018-2023)
  • Figure 5. Global Lumpectomy: by End User USD Million (2018-2023)
  • Figure 6. South America Lumpectomy Share (%), by Country
  • Figure 7. Asia Pacific Lumpectomy Share (%), by Country
  • Figure 8. Europe Lumpectomy Share (%), by Country
  • Figure 9. MEA Lumpectomy Share (%), by Country
  • Figure 10. North America Lumpectomy Share (%), by Country
  • Figure 11. Global Lumpectomy share by Players 2023 (%)
  • Figure 12. Global Lumpectomy share by Players (Top 3) 2023(%)
  • Figure 13. Global Lumpectomy share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Sanarus (United States) Revenue, Net Income and Gross profit
  • Figure 16. Sanarus (United States) Revenue: by Geography 2023
  • Figure 17. ClearCut Medical (Israel) Revenue, Net Income and Gross profit
  • Figure 18. ClearCut Medical (Israel) Revenue: by Geography 2023
  • Figure 19. BD (United States) Revenue, Net Income and Gross profit
  • Figure 20. BD (United States) Revenue: by Geography 2023
  • Figure 21. Vector Surgical (United States) Revenue, Net Income and Gross profit
  • Figure 22. Vector Surgical (United States) Revenue: by Geography 2023
  • Figure 23. Dune Medical Devices (Georgia) Revenue, Net Income and Gross profit
  • Figure 24. Dune Medical Devices (Georgia) Revenue: by Geography 2023
  • Figure 25. Medtronic PLC (Ireland) Revenue, Net Income and Gross profit
  • Figure 26. Medtronic PLC (Ireland) Revenue: by Geography 2023
  • Figure 27. ZEISS (Germany) Revenue, Net Income and Gross profit
  • Figure 28. ZEISS (Germany) Revenue: by Geography 2023
  • Figure 29. Hologic, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Hologic, Inc. (United States) Revenue: by Geography 2023
  • Figure 31. Novian Health, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Novian Health, Inc. (United States) Revenue: by Geography 2023
  • Figure 33. Cianna Medical (Merit Medical Systems, Inc.) (United States) Revenue, Net Income and Gross profit
  • Figure 34. Cianna Medical (Merit Medical Systems, Inc.) (United States) Revenue: by Geography 2023
  • Figure 35. Global Lumpectomy: by Type USD Million (2025-2030)
  • Figure 36. Global Lumpectomy: by End User USD Million (2025-2030)
  • Figure 37. South America Lumpectomy Share (%), by Country
  • Figure 38. Asia Pacific Lumpectomy Share (%), by Country
  • Figure 39. Europe Lumpectomy Share (%), by Country
  • Figure 40. MEA Lumpectomy Share (%), by Country
  • Figure 41. North America Lumpectomy Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Sanarus (United States)
  • ClearCut Medical (Israel)
  • BD (United States)
  • Vector Surgical (United States)
  • Dune Medical Devices (Georgia)
  • Medtronic PLC (Ireland)
  • ZEISS (Germany)
  • Hologic, Inc. (United States)
  • Novian Health, Inc. (United States)
  • Cianna Medical (Merit Medical Systems, Inc.) (United States)
Additional players considered in the study are as follows:
Endomagnetics (United Kingdom) , Cook Medical (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 232 Pages 61 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Lumpectomy Quantitative research analysis
Global Lumpectomy Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Lumpectomy market are Sanarus (United States), ClearCut Medical (Israel), BD (United States), Vector Surgical (United States), Dune Medical Devices (Georgia), Medtronic PLC (Ireland), ZEISS (Germany), Hologic, Inc. (United States), Novian Health, Inc. (United States) and Cianna Medical (Merit Medical Systems, Inc.) (United States), to name a few.
North America is dominating the Lumpectomy Market.
"Unavailability of Government Programs for Young Women" is seen as one of the major challenges by many Industry Players of Lumpectomy Market
The Lumpectomy market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Lumpectomy market is expected to see a steady growth rate during projected year 2023 to 2030.

Know More About Global Lumpectomy Report?

Have a Query? Click Here

Other Related Reports

Venous Thromboembolism Comprehensive Study by Type (Pneumatic Compression Sleeves (Upper, Lower), Inferior Vena Cava Filters (Permanent, Retrievable), Embolectomy Balloon Catheters, Percutaneous Thro...
$ 3750
Vaginal Slings Comprehensive Study by Type (Tension free Vaginal Tape (TVT) Slings, Transobturator Tape (TOT) Slings, Mini-Slings and Single Incision Slings), Type of Urinary Incontinence (Stress Uri...
$ 3750
Lysosomal Storage Diseases Comprehensive Study by Application (Hospitals, Ambulatory Surgical Centers), Treatment (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy), Indicat...
$ 3450
Male Infertility Comprehensive Study by Treatment (Assisted Reproductive Technology (In-Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI)), Varicocele Surgery, Medication), Test (DNA...
$ 3750
Postmenopausal Vaginal Atrophy Treatment Comprehensive Study by Type (Prasterone (Intrarosa)), Application (Vaginal estrogen cream (Estrace, Premarin). You insert this cream directly into your vagina...
$ 3650
Meningitis Diagnostic Testing Comprehensive Study by Application (Viral Meningitis, Bacterial Meningitis, Fungal Meningitis, Hib Meningitis, Others), Test Type (Latex Agglutination Tests, Lateral Flo...
$ 3650